受磷蛋白和肌浆脂质蛋白抑制的Ca(2+) -ATP酶的结构与动力学基础

Structural and dynamic basis of phospholamban and sarcolipin inhibition of Ca(2+)-ATPase.

作者信息

Traaseth Nathaniel J, Ha Kim N, Verardi Raffaello, Shi Lei, Buffy Jarrod J, Masterson Larry R, Veglia Gianluigi

机构信息

Department of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, USA.

出版信息

Biochemistry. 2008 Jan 8;47(1):3-13. doi: 10.1021/bi701668v. Epub 2007 Dec 15.

Abstract

Phospholamban (PLN) and sarcolipin (SLN) are two single-pass membrane proteins that regulate Ca2+-ATPase (SERCA), an ATP-driven pump that translocates calcium ions into the lumen of the sarcoplasmic reticulum, initiating muscle relaxation. Both proteins bind SERCA through intramembrane interactions, impeding calcium translocation. While phosphorylation of PLN at Ser-16 and/or Thr-17 reestablishes calcium flux, the regulatory mechanism of SLN remains elusive. SERCA has been crystallized in several different states along the enzymatic reaction coordinates, providing remarkable mechanistic information; however, the lack of high-resolution crystals in the presence of PLN and SLN limits the current understanding of the regulatory mechanism. This brief review offers a survey of our hybrid structural approach using solution and solid-state NMR methodologies to understand SERCA regulation from the point of view of PLN and SLN. These results have improved our understanding of the calcium translocation process and are the basis for designing new therapeutic approaches to ameliorate muscle malfunctions.

摘要

受磷蛋白(PLN)和肌浆膜蛋白(SLN)是两种单次跨膜蛋白,它们可调节Ca2 + -ATP酶(SERCA),这是一种由ATP驱动的泵,可将钙离子转运到肌浆网腔中,从而引发肌肉舒张。这两种蛋白均通过膜内相互作用与SERCA结合,从而阻碍钙转运。虽然PLN的丝氨酸-16和/或苏氨酸-17位点磷酸化可重新建立钙通量,但SLN的调节机制仍不清楚。沿着酶促反应坐标,SERCA已在几种不同状态下结晶,提供了重要的机制信息;然而,在存在PLN和SLN的情况下缺乏高分辨率晶体限制了目前对调节机制的理解。本简要综述概述了我们使用溶液和固态核磁共振方法的混合结构方法,从PLN和SLN的角度理解SERCA调节。这些结果增进了我们对钙转运过程的理解,并且是设计改善肌肉功能障碍的新治疗方法的基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索